[Federal Register Volume 84, Number 181 (Wednesday, September 18, 2019)]
[Notices]
[Pages 49110-49111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20180]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC); 
Correction

    Notice is hereby given of a change in the meeting of the Clinical 
Laboratory Improvement Advisory Committee (CLIAC); November 6, 2019, 
8:30 a.m. to 5:00 p.m., EST and November 7, 2019, 8:30 a.m. to 12:00 
p.m., EST which was published in the Federal Register on

[[Page 49111]]

August 30, 2019, Volume 84, Number 169, pages 45765-45766.
    The MATTERS TO BE CONSIDERED should read as follows: The agenda 
will include agency updates from CDC, the Centers for Medicare and 
Medicaid Services (CMS); and the Food and Drug Administration (FDA). 
Presentations and discussions will focus on a follow up on CLIAC 
recommendations; an update on the clinical laboratory workforce; 
improving integration of laboratory information systems with electronic 
health records; and future CLIAC topics. There will be an extended 
public comment session focusing on emerging technologies and the 
clinical laboratory. Agenda items are subject to change as priorities 
dictate.

FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior 
Advisor for Clinical Laboratories, Division of Laboratory Systems, 
Center for Surveillance, Epidemiology and Laboratory Services, Office 
of Public Health Scientific Services, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia 
30329-4027, telephone (404) 498-2741; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-20180 Filed 9-17-19; 8:45 am]
 BILLING CODE 4163-18-P